PMPSA’s Population Health Impact Model

9/13/21–Stanton Glantz and his colleagues at the UCSF TCORS submitted this public comment to the FDA stating that the PMPSA’s Population Health Impact Model for IQOS underestimates the health impact of IQOS, does not adequately address new published research and information on population health impacts, and does not demonstrate benefits to individual or population health, so FDA should not issue an exposure modification MRTP order for IQOS 3. Read